Urinary Bladder Dissection During Total Laparoscopic Hysterectomy in Cases With Previous Cesarean Section
Launched by MANSOURA UNIVERSITY · Oct 26, 2023
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a specific surgical technique during total laparoscopic hysterectomy, particularly for women who have had a previous cesarean section. The goal is to understand how to safely and effectively mobilize the urinary bladder from the cervix, especially when there are scar tissues from prior surgeries that could make this process more challenging. By exploring different approaches to this procedure, the researchers hope to improve outcomes and reduce complications for women undergoing this surgery.
To be eligible for this trial, participants should be women planning to have a total laparoscopic hysterectomy for non-cancerous conditions like heavy menstrual bleeding or uterine fibroids, and they must have a history of cesarean section. However, women with certain conditions, such as endometriosis or previous abdominal surgeries, will not be included. Participants can expect to be part of a study that aims to enhance surgical techniques, and they will receive careful monitoring throughout the procedure to ensure their safety. This trial is currently recruiting participants, and it seeks to gather important data that could benefit future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • .Patients undergoing total laparoscopic hysterectomy for benign conditions (e.g., dysfunctional uterine bleeding, adenomyosis and uterine fibroids) with presence of previous cesarean section scar.
- Exclusion Criteria:
- • Patients with prior abdominal surgery other than CS.
- • Patients treated with concomitant surgery, including laparoscopic pelvic lymphadenectomy, posterior vaginal colporrhaphy and tension-free vaginal or obturator tape procedures.
- • Tubo-ovarian abscess.
- • Endometriosis.
- • Pelvic tuberculosis.
- • Pelvic organ prolapses. .Patients with relative contraindication to general anesthesia (e.g. chronic liver cell failure.
- • .Patients with contraindication to laparoscopic surgery (e.g. severe cardio-pulmonary dysfunction).
- • Bleeding tendency (e.g. anticoagulants, platelets disorders)
- • Body mass index more than 35 Kg/m2
About Mansoura University
Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansoura, , Egypt
Patients applied
Trial Officials
ahmed elawady, M.Sc
Principal Investigator
Mansoura University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported